Correction

Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity

N Engl J Med 2003; 349:1487October 9, 2003

Article

Tissue Plasminogen Activator in Cardiac Arrest with Pulseless Electrical Activity (Original Article, N Engl J Med 2002:346;1522 - 1528) . In Table 3 on page 1524, the numbers and percentages of patients who received atropine should have been 108 (92.3) in the tissue plasminogen activator group and 109 (94.0) in the placebo group, and the respective numbers and percentages for sodium bicarbonate should have been 70 (59.8) and 77 (66.4), instead of the reverse, as printed.